Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors.

Sazinsky SL, Ott RG, Silver NW, Tidor B, Ravetch JV, Wittrup KD.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20167-72. doi: 10.1073/pnas.0809257105. Epub 2008 Dec 12.

2.

Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences.

Sibéril S, Dutertre CA, Boix C, Bonnin E, Ménez R, Stura E, Jorieux S, Fridman WH, Teillaud JL.

Immunol Lett. 2006 Aug 15;106(2):111-8. Epub 2006 Jun 12. Review.

PMID:
16797726
3.

Glycosylation and Fc receptors.

Hayes JM, Cosgrave EF, Struwe WB, Wormald M, Davey GP, Jefferis R, Rudd PM.

Curr Top Microbiol Immunol. 2014;382:165-99. doi: 10.1007/978-3-319-07911-0_8. Review.

PMID:
25116100
4.

Type I and type II Fc receptors regulate innate and adaptive immunity.

Pincetic A, Bournazos S, DiLillo DJ, Maamary J, Wang TT, Dahan R, Fiebiger BM, Ravetch JV.

Nat Immunol. 2014 Aug;15(8):707-16. doi: 10.1038/ni.2939. Review.

PMID:
25045879
5.

Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.

Caaveiro JM, Kiyoshi M, Tsumoto K.

Immunol Rev. 2015 Nov;268(1):201-21. doi: 10.1111/imr.12365. Review.

PMID:
26497522
6.

Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.

Lu J, Sun PD.

Immunol Rev. 2015 Nov;268(1):192-200. doi: 10.1111/imr.12346. Review.

PMID:
26497521
7.

Isotype and glycoform selection for antibody therapeutics.

Jefferis R.

Arch Biochem Biophys. 2012 Oct 15;526(2):159-66. doi: 10.1016/j.abb.2012.03.021. Epub 2012 Mar 23. Review.

PMID:
22465822
8.

The effector functions of immunoglobulins: implications for therapy.

Ward ES, Ghetie V.

Ther Immunol. 1995 Apr;2(2):77-94. Review.

PMID:
8729879
9.

Fc-receptors as regulators of immunity.

Nimmerjahn F, Ravetch JV.

Adv Immunol. 2007;96:179-204. Review.

PMID:
17981207
10.

Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics.

Ju MS, Jung ST.

Curr Opin Biotechnol. 2014 Dec;30:128-39. doi: 10.1016/j.copbio.2014.06.013. Epub 2014 Jul 16. Review.

PMID:
25035939
11.

IgG-effector functions: "the good, the bad and the ugly".

Kapur R, Einarsdottir HK, Vidarsson G.

Immunol Lett. 2014 Aug;160(2):139-44. doi: 10.1016/j.imlet.2014.01.015. Epub 2014 Feb 1. Review.

PMID:
24495619
12.

Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.

Wang Y, Tian Z, Thirumalai D, Zhang X.

J Drug Target. 2014 May;22(4):269-78. doi: 10.3109/1061186X.2013.875030. Epub 2014 Jan 9. Review.

PMID:
24404896
13.

Heterogeneity of human IgG Fc receptors.

Capel PJ, van de Winkel JG, van den Herik-Oudijk IE, Verbeek JS.

Immunomethods. 1994 Feb;4(1):25-34. Review.

PMID:
8069524
14.

Engineering therapeutic antibodies for improved function.

Presta LG, Shields RL, Namenuk AK, Hong K, Meng YG.

Biochem Soc Trans. 2002 Aug;30(4):487-90. Review.

PMID:
12196120
15.

Fc gamma receptors: glycobiology and therapeutic prospects.

Hayes JM, Wormald MR, Rudd PM, Davey GP.

J Inflamm Res. 2016 Nov 16;9:209-219. eCollection 2016. Review.

16.

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

van de Winkel JG, Capel PJ.

Immunol Today. 1993 May;14(5):215-21. Review.

PMID:
8517920
17.

Factors influencing the endocytosis of immune complexes.

van Es LA, Daha MR.

Adv Nephrol Necker Hosp. 1984;13:341-67. Review.

PMID:
6236677
18.

IgG-Fc receptors and the clinical relevance of their polymorphisms.

de Haas M.

Wien Klin Wochenschr. 2001 Oct 30;113(20-21):825-31. Review.

PMID:
11732118
19.

FcγRs in health and disease.

Nimmerjahn F, Ravetch JV.

Curr Top Microbiol Immunol. 2011;350:105-25. doi: 10.1007/82_2010_86. Review.

PMID:
20680807
20.

[Nonclinical Evaluation of Next-generation Therapeutic Monoclonal Antibodies].

Ishii-Watabe A, Tada M, Suzuki T, Kawasaki N.

Yakugaku Zasshi. 2015;135(7):857-66. doi: 10.1248/yakushi.15-00007-3. Review. Japanese.

Supplemental Content

Support Center